John L. Leguyader

Array ( [id] => 4010968 [patent_doc_number] => 05879907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Artificial gene coding for authentic human serum albumin, use thereof and method' [patent_app_type] => 1 [patent_app_number] => 7/884274 [patent_app_country] => US [patent_app_date] => 1992-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 20987 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/879/05879907.pdf [firstpage_image] =>[orig_patent_app_number] => 884274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3064166 [patent_doc_number] => 05352607 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-04 [patent_title] => 'Molecular clone of a chitinase gene from vibrio parahemolyticus' [patent_app_type] => 1 [patent_app_number] => 7/876894 [patent_app_country] => US [patent_app_date] => 1992-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3608 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/352/05352607.pdf [firstpage_image] =>[orig_patent_app_number] => 876894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2892640 [patent_doc_number] => 05240841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-31 [patent_title] => 'E. coli resistance to Q.beta. virus infection' [patent_app_type] => 1 [patent_app_number] => 7/856889 [patent_app_country] => US [patent_app_date] => 1992-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11807 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/240/05240841.pdf [firstpage_image] =>[orig_patent_app_number] => 856889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930928 [patent_doc_number] => 05928863 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Triple-stranded nucleic acids' [patent_app_type] => 1 [patent_app_number] => 7/841218 [patent_app_country] => US [patent_app_date] => 1992-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 8157 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928863.pdf [firstpage_image] =>[orig_patent_app_number] => 841218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727054 [patent_doc_number] => 05652094 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Nucleozymes' [patent_app_type] => 1 [patent_app_number] => 7/829729 [patent_app_country] => US [patent_app_date] => 1992-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6505 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652094.pdf [firstpage_image] =>[orig_patent_app_number] => 829729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3084163 [patent_doc_number] => 05284768 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-08 [patent_title] => 'Signal peptide, DNA sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide' [patent_app_type] => 1 [patent_app_number] => 7/825080 [patent_app_country] => US [patent_app_date] => 1992-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5304 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/284/05284768.pdf [firstpage_image] =>[orig_patent_app_number] => 825080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3954207 [patent_doc_number] => 05935829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Mutation assays involving blood cells that metabolize toxic substances' [patent_app_type] => 1 [patent_app_number] => 7/817971 [patent_app_country] => US [patent_app_date] => 1992-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9609 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935829.pdf [firstpage_image] =>[orig_patent_app_number] => 817971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4054144 [patent_doc_number] => 05932697 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Synthetic antifreeze peptide' [patent_app_type] => 1 [patent_app_number] => 7/812421 [patent_app_country] => US [patent_app_date] => 1991-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9386 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932697.pdf [firstpage_image] =>[orig_patent_app_number] => 812421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3070825 [patent_doc_number] => 05360742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-01 [patent_title] => 'Eukaryotic plasmid vector encoding enzymes for cysteine production' [patent_app_type] => 1 [patent_app_number] => 7/814247 [patent_app_country] => US [patent_app_date] => 1991-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 5780 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/360/05360742.pdf [firstpage_image] =>[orig_patent_app_number] => 814247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4021420 [patent_doc_number] => 05925540 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Synthetic antifreeze peptide and synthetic gene coding for its production' [patent_app_type] => 1 [patent_app_number] => 7/814220 [patent_app_country] => US [patent_app_date] => 1991-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 9381 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925540.pdf [firstpage_image] =>[orig_patent_app_number] => 814220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2878771 [patent_doc_number] => 05118793 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-02 [patent_title] => 'Modified heparin cofactor II' [patent_app_type] => 1 [patent_app_number] => 7/791693 [patent_app_country] => US [patent_app_date] => 1991-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 4167 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/118/05118793.pdf [firstpage_image] =>[orig_patent_app_number] => 791693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3528051 [patent_doc_number] => 05582967 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Human cell line LC5 and its use' [patent_app_type] => 1 [patent_app_number] => 7/635112 [patent_app_country] => US [patent_app_date] => 1991-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2550 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/582/05582967.pdf [firstpage_image] =>[orig_patent_app_number] => 635112 [rel_patent_id] =>[rel_patent_doc_number] =>)